Engineering macrophages for cancer immunotherapy and drug delivery
Y ** polarization and targeting
Q Zhang, M Sioud - International journal of molecular sciences, 2023 - mdpi.com
The tumor microenvironment (TME) is a critical regulator of tumor growth, progression, and
metastasis. Among the innate immune cells recruited to the tumor site, macrophages are the …
metastasis. Among the innate immune cells recruited to the tumor site, macrophages are the …
[HTML][HTML] Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes
S Han, W Wang, S Wang, T Yang, G Zhang, D Wang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Background: Among the many immunosuppressive cells in the tumor microenvironment,
tumor-associated-macrophages (TAMs) are well known to contribute to tumor development …
tumor-associated-macrophages (TAMs) are well known to contribute to tumor development …
Tumor associated macrophages: origin, recruitment, phenotypic diversity, and targeting
The tumor microenvironment (TME) is known to have a strong influence on tumorigenesis,
with various components being involved in tumor suppression and tumor growth. A …
with various components being involved in tumor suppression and tumor growth. A …
Progress on modulating tumor‐associated macrophages with biomaterials
M Sylvestre, CA Crane, SH Pun - Advanced Materials, 2020 - Wiley Online Library
Tumor‐associated macrophages (TAMs) are a complex and heterogeneous population of
cells within the tumor microenvironment. In many tumor types, TAMs contribute toward tumor …
cells within the tumor microenvironment. In many tumor types, TAMs contribute toward tumor …
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B
YS Ma, TM Wu, CC Ling, F Yu, J Zhang, PS Cao… - Molecular Therapy …, 2021 - cell.com
Previous evidence has highlighted M2 macrophage regulation of cancer cells via exosome
shuttling of microRNAs (miRNAs or miRs). The current study set out to explore the possible …
shuttling of microRNAs (miRNAs or miRs). The current study set out to explore the possible …
Design of polymeric carriers for intracellular peptide delivery in oncology applications
In recent decades, peptides, which can possess high potency, excellent selectivity, and low
toxicity, have emerged as promising therapeutics for cancer applications. Combined with an …
toxicity, have emerged as promising therapeutics for cancer applications. Combined with an …
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Y Jiang, Z Jiang, M Wang, L Ma - Advanced drug delivery reviews, 2022 - Elsevier
Breast cancer is one of the most frequently diagnosed cancers that is threatening women's
life. Current clinical treatment regimens for breast cancer often involve neoadjuvant and …
life. Current clinical treatment regimens for breast cancer often involve neoadjuvant and …